SHOULDER INNOVATIONS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
SHOULDER INNOVATIONS, INC. (SI) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$40.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$40.00K, a 4100.00% decline year-over-year.
- SHOULDER INNOVATIONS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$181.00K.
- SHOULDER INNOVATIONS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $78.00K.
- SHOULDER INNOVATIONS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$43.00K, a 170.49% decline year-over-year.
- SHOULDER INNOVATIONS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$80.00K.
- SHOULDER INNOVATIONS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$159.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$40.00K 10-Q · filed 2026-08-06 | -$221.00K 10-Q · filed 2026-08-06 | -$143.00K derived: sum of 3 quarters · filed 2026-08-06 | -$186.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$181.00K 10-Q · filed 2026-08-06 | -$103.00K derived: sum of 2 quarters · filed 2026-08-06 | -$146.00K derived: sum of 3 quarters · filed 2026-08-06 | -$145.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $35.00K derived: sum of 2 quarters · filed 2026-03-10 | $36.00K derived: sum of 3 quarters · filed 2026-08-06 | -$80.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | -$43.00K 10-Q · filed 2025-11-12 | -$42.00K derived: sum of 2 quarters · filed 2026-08-06 | -$158.00K 10-Q · filed 2025-11-12 | -$363.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-06 | -$115.00K 10-Q · filed 2026-08-06 | -$320.00K derived: sum of 3 quarters · filed 2026-08-06 | -$259.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$116.00K 10-Q · filed 2026-08-06 | -$321.00K derived: sum of 2 quarters · filed 2026-08-06 | -$260.00K derived: sum of 3 quarters · filed 2026-08-06 | -$317.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$144.00K derived: sum of 2 quarters · filed 2026-03-10 | -$201.00K derived: sum of 3 quarters · filed 2026-03-10 | -$159.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $61.00K 10-Q · filed 2025-11-12 | $4.00K derived: sum of 2 quarters · filed 2025-11-12 | $46.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$57.00K 10-Q · filed 2025-11-12 | -$15.00K 10-Q · filed 2025-09-09 | ||
| 2024-03-31 | $42.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |